Date: Thu, 13 Jun 2002 09:31:03 -0400 Subject: When Money Corrupts Medicine – Deaths Occur ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.researchprotection.org Contact: Vera Hassner Sharav FYI The Boston Globe reported that the family of Roger Darke who died in a gene therapy experiment conducted by the late Dr. Jeffrey…
Eli Lilly Prozac UK Fact Sheet: “Not Recommended” for Children – PMDD Withdrawn in UK Fri, 19 Dec 2003 The Alliance for Human Research Protection has obtained copies of two Eli Lilly documents that were sent to all physicians in the UK yesterday. A letter informs doctors in the UK…
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 Fax: 212-595-9086 142 West End Ave. Suite 28P New York, NY 10023 Co-founders: Vera Hassner Sharav, President John H. Noble, Jr., PhD, Treasurer David Cohen, Ph.D., Secretary March 27, 2003 March 27, 2003 Senate Committee on Health, Education, Labor, and Pensions Dear…
FDA Requests Fed Investigation Of Itself After It Lost Medical Records Wed, 16 Apr 2003 FDA Commissioner, Dr. Mark McClelan has requested an independent investigation of a bone density study conducted jointly by an FDA investigator and another affiliated with the Henry Jackson Foundation for the Advancement of Military Medicine….
Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions? Wed, 22 Sep 2004 FDA’s complicity in concealing vital drug safety information that might have saved lives, is the subject of tomorrow’s hearing by the House subcommittee on Oversight and Investigations. Rayburn Office Bldg, room 2123 at 11:00….
A Disease for Every Pill – FDA Hearing Drug Advertising Wed, 5 Oct 2005 The FDA has called for a public hearing to address direct to consumer drug advertising. Hearing Date: November 1 and 2, 2005 Hearing Name: Direct-To-Consumer Promotion Location: National Transportation Safety Board Boardroom and Conference Center 429…
NIMH Offers Grants to Study SSRI relation to Suicidality_FDA to Examine SSRI- Suicide in Adults Mon, 14 Nov 2005 A fifteen year struggle by critics of the drug-centered treatment paradigm in psychiatry is being indirectly validated both by the FDA and the National Institute of Mental Health who are addressing…
Subject: BioMedNet: FDA Divorces Chemistry from Biology Date: Sun, 15 Sep 2002 10:25:07 -0400 FDA maintains two administrative oversight branches for medical products: Center for Biologics Evaluation and Research (CBER)–is responsible for overseeing the safety of bio-tech based therapies, vaccines, blood safety, and gene therapy. Center for Drug Evaluation and…
Forbes: Judgment Day for the FDA, Pfizer Wed, 9 Feb 2005 On Feb. 16-18 COX-2 Inhibitor Safety Issues will be the focus of an FDA Advisory Committee and (simultaneously) the European Medicines Agency (EMA). The entire drug industry will be watching with bated breath. Which causal explanation will be offered…
FDA Critics Slam Plan for Safety Reform – Nature Thu, 17 Feb 2005 This is smoke and mirrors and musical chairs. Vera Sharav Alliance for Human Research Protection, New York http://www.nature.com/news/2005/050214/full/050214-11.html Published online: 17 February 2005; | doi:10.1038/news050214-11 FDA critics slam plan for safety reform Emma Marris Calls grow for…
Anthrax Vaccine Consent Form / Should You Roll Up Your Sleeves_WSJ Sat, 29 Mar 2003 The Administration’s determination to push its two controversial vaccine programs forward–smallpox and anthrax–even as medical experts urge caution in light of the serious health risks posed by these vaccines – raises serious questions about whose…
The Children’s Hospital of Philadelphia Department of Anesthesiology and Critical Care Medicine Robert M. Nelson, M.D., Ph.D. 34th Street & Civic Center Boulevard, Rm. 1513 Chair, Committees for the Protection of Human Subjects Philadelphia, Pennsylvania 19104-4399 Associate Professor of Anesthesia and Pediatrics (215) 590-9180 Office (267) 426-5035 Fax November 25,…
